Market Overview – The market for orphan pharmaceuticals was estimated to be worth USD 160.78 billion in 2021 and is expected to increase to USD 355.00 billion by 2030, showing a 9.20% compound annual growth rate (CAGR) between 2022 and 2035. The Orphan Drugs Market is a niche segment of the pharmaceutical industry dedicated to treating rare diseases. These diseases, often affecting a...